Your browser doesn't support javascript.
loading
Prognostic importance of ischemic heart disease for patients with atrial fibrillation undergoing catheter ablation.
Espersen, Caroline; Modin, Daniel; Johansen, Niklas Dyrby; Janstrup, Kira Hyldekær; Johannessen, Arne; Hansen, Jim; Eskesen, Kristian; Iversen, Allan Zeeberg; Worck, René H; Ruwald, Martin H; Hansen, Morten Lock; Gislason, Gunnar H; San José Estépar, Raúl; Marcus, Gregory M; Biering-Sørensen, Tor.
Afiliação
  • Espersen C; Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical S
  • Modin D; Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical S
  • Johansen ND; Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical S
  • Janstrup KH; Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical S
  • Johannessen A; Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark.
  • Hansen J; Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark.
  • Eskesen K; Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark.
  • Iversen AZ; Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark.
  • Worck RH; Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark.
  • Ruwald MH; Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark.
  • Hansen ML; Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark.
  • Gislason GH; Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark; The Danish Heart Foundation, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • San José Estépar R; Applied Chest Imaging Laboratory, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Marcus GM; Department of Cardiology, University of California, San Francisco, California.
  • Biering-Sørensen T; Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Hellerup, Denmark; Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical S
Heart Rhythm ; 2024 Aug 13.
Article em En | MEDLINE | ID: mdl-39147302
ABSTRACT

BACKGROUND:

Ischemic heart disease (IHD) has been linked to an increased risk of atrial fibrillation (AF). However, data are sparse regarding the role of IHD in AF recurrence after catheter ablation.

OBJECTIVE:

We sought to investigate whether preexisting or new-onset IHD is associated with a greater risk of AF recurrence after ablation.

METHODS:

With use of Danish nationwide registries, all patients undergoing first-time AF ablation in Denmark from 2010 to 2020 were identified. The primary outcome was AF recurrence defined by AF-related hospital admission or antiarrhythmic drug use within 1 year after ablation excluding a 3-month blanking period. IHD was defined as an International Classification of Diseases, Tenth Revision diagnosis of IHD or prior coronary revascularization.

RESULTS:

Of 12,162 patients undergoing first-time ablation for AF (mean age, 62 years; 30% female), 20% had preexisting IHD. Preexisting IHD was associated with an increased risk of AF recurrence in univariable log-binomial logistic regression (relative risk, 1.09; 95% CI, 1.04-1.14; P < .001). However, after multivariable adjustment including procedural year, preexisting IHD was no longer associated with an increased risk of AF recurrence (relative risk, 1.02; 95% CI, 0.97-1.06; P = .42). In a nested case-control study of those without preexisting IHD before ablation (n = 9778), newly diagnosed IHD after ablation was associated with an increased risk of AF recurrence in multivariable analysis (hazard ratio, 3.03; 95% CI, 1.84-4.99; P < .001).

CONCLUSION:

The presence of IHD does not appear to reduce the effectiveness of AF ablation procedures. However, the emergence of IHD after AF ablation may serve as a trigger for AF that is insufficiently suppressed by prior ablation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article